LIPOPROTEIN INCREASED

LIPOPROTEIN INCREASED was reported 47 times

These drug classes are most commonly taken by patients reporting LIPOPROTEIN INCREASED:

# Drug Count
0 HER2/neu Receptor Antagonist [EPC] 7
1 Microtubule Inhibitor [EPC] 6
2 Nonsteroidal Anti-inflammatory Drug [EPC] 6
3 Platinum-based Drug [EPC] 6
4 GLP-1 Receptor Agonist [EPC] 5
5 Corticosteroid [EPC] 4
6 Dietary Cholesterol Absorption Inhibitor [EPC] 4
7 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 4
8 HMG-CoA Reductase Inhibitor [EPC] 4
9 Platelet Aggregation Inhibitor [EPC] 4
10 Angiotensin 2 Receptor Blocker [EPC] 3
11 Janus Kinase Inhibitor [EPC] 2
12 PCSK9 Inhibitor [EPC] 2
13 5-alpha Reductase Inhibitor [EPC] 1
14 Aldosterone Antagonist [EPC] 1
15 Amide Local Anesthetic [EPC] 1
16 Antiarrhythmic [EPC] 1
17 Arteriolar Vasodilator [EPC] 1
18 Azole Antifungal [EPC] 1
19 CD20-directed Cytolytic Antibody [EPC] 1
20 Dihydropyridine Calcium Channel Blocker [EPC] 1
21 Endothelin Receptor Antagonist [EPC] 1
22 Expectorant [EPC] 1
23 Folate Analog Metabolic Inhibitor [EPC] 1
24 Interleukin-12 Antagonist [EPC] 1
25 Interleukin-23 Antagonist [EPC] 1
26 Interleukin-4 Receptor alpha Antagonist [EPC] 1
27 Kinase Inhibitor [EPC] 1
28 Loop Diuretic [EPC] 1
29 Muscle Relaxant [EPC] 1
30 Nicotinic Acid [EPC] 1
31 Non-narcotic Antitussive [EPC] 1
32 P2Y12 Platelet Inhibitor [EPC] 1
33 Progestin [EPC] 1
34 Purine Antimetabolite [EPC] 1
35 Recombinant Human Growth Hormone [EPC] 1
36 Serotonin-3 Receptor Antagonist [EPC] 1
37 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
38 Tissue-nonspecific Alkaline Phosphatase [EPC] 1